Latest Alligator Bioscience News & Updates

See the latest news and media coverage for Alligator Bioscience. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Alligator Bioscience

Clinical-stage biotechnology company developing tumor-directed cancer immunotherapies

alligatorbioscience.se
Headquarters
Lund, Sweden
Founded year
2001
Company type
Public company
Number of employees
25–50

Last updated

Latest news about Alligator Bioscience

In short: Alligator Bioscience improved its Q1 2026 financial results, reported progress for mitazalimab, and raised $19 million through warrant exercises.

Company announcements

  • Alligator Bioscience

    Alligator Bioscience welcomes two new board members

    Joerg Moeller and Anna Törner bring biotech and governance expertise and join as Alligator advances mitazalimab, a Phase 3‑ready antibody for metastatic pancreatic cancer.

  • Alligator Bioscience

    Alligator Bioscience holds annual general meeting

    Resolutions adopt accounts, discharge board and CEO, elect new board members including Hans-Peter Ostler as Chairman, re-elect PwC as auditor, approve remuneration report, and authorize share issues.

  • Alligator Bioscience

    Alligator Bioscience releases Q1 2026 report

    CEO and CFO present it in a webinar today at 1 p.m. CEST with Q&A.

  • Alligator Bioscience

    Alligator Bioscience reports Q1 2026 financial results

    Presents mitazalimab updates, HLX22 progress, and capital raise of 19 MSEK. Operating loss is 17.8 MSEK.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Alligator Bioscience

Track Alligator Bioscience and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Alligator Bioscience competitors & trending companies

Browse news for competitors to Alligator Bioscience and other trending companies.